Jessey F. Wright
Sterling Way
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
The promising potential of gene therapy for diabetes mellitus.
Journal: Nature reviews. Endocrinology
Published: August 29, 2024
Erratum: AAV vector production: Troublesome host innate responses in another setting.
Journal: Molecular therapy. Methods & clinical development
Published: August 28, 2023
Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey.
Journal: Journal of neurology
Published: August 24, 2023
Re-administration of AAV vectors by masking with host albumin: A Goldilocks hypothesis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 25, 2023
AAV vector production: Troublesome host innate responses in another setting.
Journal: Molecular therapy. Methods & clinical development
Published: March 13, 2023
UK Haemoglobin Disorders Peer Review: A Quality Standards-based review programme for sickle cell disease and thalassaemia.
Journal: British journal of haematology
Published: March 02, 2023
AAV vector manufacturing process design and scalability - Bending the trajectory to address vector-associated immunotoxicities.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 05, 2022
Design of experiments as a decision tool for cell therapy manufacturing.
Journal: Cytotherapy
Published: October 12, 2021
Psychiatric liaison service referral patterns during the UK COVID-19 pandemic: An observational study.
Journal: The European journal of psychiatry
Published: March 31, 2021
Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes.
Journal: Frontiers in immunology
Published: March 04, 2021
The intersection of vector biology, gene therapy, and hemophilia.
Journal: Research and practice in thrombosis and haemostasis
Published: February 12, 2021
Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's Disease.
Journal: International journal of toxicology
Published: November 02, 2020
Last Updated: 09/26/2026